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Determining the differentiation potential of stem and progenitor cells is 
essential for understanding their function, yet our ability to do so is limited by 
the restrictions of experimental assays. Based on single-cell functional and 
molecular profiling experiments, a new computational approach shows how 
lineage commitment may occur in human haematopoiesis. 
 
Diagrams depicting haematopoiesis as a branching process, with stem cells 
at the top of a differentiation hierarchy, are a familiar sight in any textbook 
referring to the haematopoietic system1. Developed and refined over the past 
few decades, this classical model proposes that haematopoietic stem cells 
(HSCs) undergo stepwise differentiation into discrete progenitor populations 
on their journey to mature blood cells. Yet, in recent years, advances in 
single-cell technologies have provided new insights challenging this classical 
view of haematopoiesis, which instead argue for a more continuous process 
and against the existence of some of the previously defined progenitor 
populations. In this issue, Velten and colleagues2 investigate the fate 
decisions made during human adult haematopoiesis by presenting combined 
analysis of single-cell transcriptional and functional data. Similar to a recent 
report3, they find that whilst multipotent cells exist in the adult stem cell 
compartment, the majority of blood progenitor cells are in fact unipotent. This 
observation is in marked contrast to the traditional branching model with its 
stepwise progression from stem cells via multipotent to bipotent and finally 
unipotent progenitors.  
 To define the gene expression states associated with cell fate decision 
making in adult human haematopoiesis, the authors generated single-cell 
RNA-sequencing (scRNA-Seq) profiles by sampling the stem and progenitor 
compartment from adult human bone marrow. Importantly, the authors used 
index flow sorting4 so that each single-cell molecular profile could be assigned 
to a classically-defined cell type based on combinatorial surface marker 
expression. This approach revealed that cells within the more mature 
progenitor compartment (defined based on surface marker expression) could 
be separated into discrete cell states by approaches including clustering 
algorithms, with different states showing gene expression that suggested 
clear lineage priming. By contrast, less mature cells did not resolve into 
similarly clear populations when analysed with the same bioinformatic tools. 
The less mature cell compartment included cells with surface marker 
phenotypes historically associated with cells such as multipotent progenitors 
(MPPs) and multilymphoid progenitors (MLPs), which retain the multipotent 
state of HSCs, yet have lost the potential for long term self-renewal. These 
findings therefore hinted at an incompatibility with the classical branching 
model, as there was little evidence for cell states that might occupy 
intermediate bi- or tri-potent states on the journey from multipotent to 
unipotent cells.  
 
It is worth highlighting the highly interactive website that accompanies the 
paper, which allows researchers to perform basic analyses on data from the 
study without the need for any specialist bioinformatics expertise. To process 
the raw data from scratch would require investing considerable time and 
effort, hence making the data available for online exploration represents a 
highly valuable resource. A particular asset for the haematopoiesis community 
(which we hope will continue to be available online) is that the flow cytometry 
index data are linked with the scRNA-Seq molecular profiles, so that any user 
can query gene expression and/or molecular heterogeneity for the exact 
populations of human blood stem and progenitor cells that for over a decade 
scientists in the field have worked hard to define. 
 
As cells differentiate, they undergo noticeable changes in gene expression, 
which are reflected in the molecular profiles measured by scRNA-Seq. This 
raises the exciting possibility of utilising single-cell snapshot data to either 
validate or invalidate the proposed structure of the haematopoietic hierarchy. 
As individual profiles represent expression states of real cells progressing 
through differentiation, software can be developed with the specific aim of 
exploiting the strength of similarities between single-cell profiles to construct 
putative differentiation journeys. Existing algorithms, such as diffusion 
pseudotime (DPT)5 and Wishbone6, aim to organize differentiating cells along 
branching trajectories. For this study on human haematopoiesis the authors 
developed a new approach specifically suited to a system with extensive pre-
existing knowledge about the start and end points of individual trajectories, 
which does not assume the constraint of a branching structure. These 
requirements led to the innovation of the STEMNET algorithm, which uses 
genes specifically expressed in different blood lineages to score each cellular 
profile based on its lineage bias and strength of commitment. Assessment of 
these scores across the whole data set enables identification of cells that 
possess the potential for multiple fates, and also of the precise combinations 
of multi- or bipotent fates that exist. 
 
Importantly, scRNA-Seq profiles report expression states in unperturbed 
haematopoiesis, for which specific fate tracking of individual stem or 
progenitor cells has been impossible to date. Classical functional assays 
involve a perturbation of the system, such as placing cells into in vitro culture 
or transplanting them into an irradiated and therefore abnormal bone marrow 
environment. For this reason, functional assays report the potential of a cell in 
those specific assay conditions, rather than its fate in unperturbed 
haematopoiesis. Bearing in mind these caveats, it is nevertheless critical that 
computational predictions should be accompanied by functional validation. A 
particular challenge of high dimensional transcriptomics data is that profiling 
gene expression of a cell via RNA-Seq necessitates its destruction, thereby 
ruling out the possibility of testing its potential in any way. To circumvent this 
problem, the authors used the same cell surface markers, measured by index 
sorting, for the functional assays and scRNA-Seq, an approach that has 
previously been described for studies in mouse4,7. The combined results of in 
vitro culture and xenotransplantation assays with the STEMNET predictions 
challenged the classical step-by-step branching model of haematopoiesis. 
Strikingly, the authors showed a lack of well-defined hierarchically organized 
discrete progenitor populations, with the majority of cells in fact appearing to 
be either multipotent, or committed to just a single fate. The uncommitted cells 
were described as CLOUD-HSPCs (a Continuum of LOw-primed 
UnDifferentiated haematopoietic stem and progenitor cells) as they could not 
be separated based on lineage commitment, but instead seemed to reside in 
a more continuous compartment (Figure 1). However, it remains to be 
established to what extent a continuous change in gene expression indicates 
a continuous change in potential, as variations in other factors that may not be 
directly reflected in the transcriptome of a cell are likely to play an important 
role in its fate restriction. Another possibility is that transcriptional noise in 
biologically irrelevant genes may obscure expression changes in a small 
number of key regulators from current bioinformatic analysis tools. Such 
changes in key regulators may in turn define discrete, rather than continuous 
cellular states within the immature HSPC compartment. 
 
The results of single-cell culture assays described in this paper echo those 
published last year by Dick and colleagues3, who contrasted the output of 
culturing single human HSPCs in colony assays at different developmental 
time points. Both studies found that in human adult bone marrow the majority 
of bi- or multipotent cells (based on colony output) were restricted to the stem 
and early progenitor compartment, with only small numbers of later progenitor 
cells giving rise to multiple lineages. Although the two studies observed that 
differentiation potential was clearly reduced as cells matured from the earlier 
to the later compartment, it is worth noting that both still found a small 
proportion of bi- and multipotent cells present in the progenitor compartment. 
The detection of even small numbers of multipotent progenitors raises the 
question of what makes these cells different from the majority of unipotent 
cells? Is this small percentage a true reflection of the in vivo potential or is it 
linked to limitations of culture assays? Finding an answer to these questions 
will pose a challenge especially in the human system, for which it is currently 
impossible to assay the ‘true’ in vivo potential of a cell, as all conclusions are 
derived from in vitro and xenotransplantation experiments. Additionally, 
assays are limited by their ability to only resolve broad classes of cell types 
(erythroid, megakaryocytic and myeloid), without the full range of more 
specific fates that can be detected based on gene expression states.  
 
Applied to single-cell molecular profiles, methods such as STEMNET promise 
the exciting ability to look into the future of an individual cell, predicting all its 
possible fates. Intriguingly, methods are also emerging that will allow us to 
look back into the history of a cell. Transgenic CrispR scarring approaches for 
example can generate barcode sequences that are maintained over 
subsequent generations and can therefore be used to retrospectively assign 
lineage relationships8. While transgenic methods are not applicable in human, 
their use in model systems such as the mouse may still provide insights of 
relevance to human biology. Rapid developments in ‘multi-omics’ single-cell 
techniques9,10,11,12 will allow the determination of multiple properties of 
individual cells (for instance, through parallel sequencing of a single cell’s 
transcriptome and genome). When combined with appropriate computational 
methods, these approaches open up promising new opportunities to capture 
the past as well as predict the future of a single cell from static snapshot data 
alone, and thus substantially advance our ability to gain new insights into how 
cell fate decisions are regulated across multiple biological systems.  
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 Figure legend: 
Left hand side: In the classical model of haematopoiesis, haematopoietic stem 
cells (HSCs) undergo stepwise differentiation, first losing their self-renewal 
potential and differentiating into multipotent progenitors (MPPs) before further 
commitment into pools of progenitors committed to different lineages. Right 
hand side: Alternatively, Velten and colleagues2 propose a model of a 
Continuum of LOw-primed UnDifferentiated (“CLOUD”)-HSPCs, in which 
differentiation does not occur as a branching process. The continuum consists 
of un-committed cells in transitory states, which gradually acquire 
transcriptomic lineage priming, ultimately resulting in the emergence of 
differentiated uni-lineage progenitors.  
